RxDoctor Payments Data

Natalie Bateson, PA

Physician Assistant · Johnson City, TNNPI 1033589023

Payments from drug & device makers

$3,956in general payments, 2019–2025

Across 234 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$903
  • AstraZeneca$542
  • Sanofi$335
  • Regeneron Healthcare Solutions, Inc.$310
  • Grifols USA, LLC$304
  • Insmed, Inc.$252
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$3,91299%
  • Education$441%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,956 in reported general payments places this provider in the 85th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$27,537
Medicare patients
120
Services billed
376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter506$410,305
Breztri AerosphereBudesonide/Glycopyr/Formoterol127$93,853
Spiriva HandihalerTiotropium Bromide60$40,164
Stiolto RespimatTiotropium Br/Olodaterol Hcl50$28,064
Spiriva RespimatTiotropium Bromide44$27,597
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr46$26,391
Combivent RespimatIpratropium/Albuterol Sulfate26$22,193
SymbicortBudesonide/Formoterol Fumarate64$21,729
Breo ElliptaFluticasone/Vilanterol31$14,218
Pirfenidone14$13,389
Albuterol Sulfate HfaAlbuterol Sulfate481$10,629
Bevespi AerosphereGlycopyrrolate/Formoterol Fum15$9,743
Roflumilast91$7,578
Advair HfaFluticasone Propion/Salmeterol21$6,651
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate32$6,486

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$903$455,194595 claims
AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere$542$125,326206 claims
Boehringer IngelheimStiolto Respimat, Spiriva Respimat, Combivent Respimat$93$77,854120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →